15 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison ... #pharmacology #table ... #medications #comparison ... #drugs #treatment ... pharmacotherapy #dermatology
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... Tobacco Cessation Treatment ... Cessation #Therapy #Comparison ... #Table #Agents ... #Dosing
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology ... #warfarin #dosing
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
#pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
NS vs Balanced Solutions - Comparison of clinical outcomes. 
#EBM #Nephrology #Saline #Balanced #Fluids #Trials #Comparison
of clinical outcomes ... #EBM #Nephrology ... Saline #Balanced #Fluids ... #Trials #Comparison ... #Table #Outcomes
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
#clinical #management ... anesthesiology #anesthesia #medication ... Amidate (etomidate) dosing ... KL, Fitzgerald BM ... Effects, Dosages, Treatment
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... summarised in Tables ... 5.2 and 5.4 #EBM ... Personality #Disorder #Medications ... Effectiveness #Table
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison ... Table Some patients ... interested in medication ... assisted treatment ... Dosing usually begins
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... : No • Treatment ... #diagnosis #comparison ... #table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... the use of this medication ... won’t have any clinical